Autor: "Zannad, Faiez" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Comparing and contrasting risk factors for heart failure in patients with and without history of myocardial infarction: data from HOMAGE and the UK Biobank.
Autorzy:: Rastogi T; Centre d'Investigations Cliniques Plurithématique 1433, Institut Lorrain du Cœur et des Vaisseaux Louis Mathieu, CHRU de Nancy, INSERM DCAC, F-CRIN INI-CRCT, Université de Lorraine, Nancy, France.
Ho FK; Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.
Rossignol P; Centre d'Investigations Cliniques Plurithématique 1433, Institut Lorrain du Cœur et des Vaisseaux Louis Mathieu, CHRU de Nancy, INSERM DCAC, F-CRIN INI-CRCT, Université de Lorraine, Nancy, France.
Merkling T; Centre d'Investigations Cliniques Plurithématique 1433, Institut Lorrain du Cœur et des Vaisseaux Louis Mathieu, CHRU de Nancy, INSERM DCAC, F-CRIN INI-CRCT, Université de Lorraine, Nancy, France.
Butler J; Department of Medicine, University of Mississippi School of Medicine, Jackson, MS, USA.
Clark A; Hull York Medical School, Castle Hill Hospital, Cottingham, UK.
Collier T; London School of Hygiene and Tropical Medicine, London, UK.
Delles C; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
Jukema JW; Department of Cardiology, Leiden University Medical Center, Leiden; Netherlands Heart Institute, Utrecht, The Netherlands.
Heymans S; Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, The Netherlands.; Department of Cardiovascular Research, University of Leuven, Leuven, Belgium.; Netherlands Heart Institute, Utrecht, The Netherlands.
Latini R; IRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Mebazaa A; Université de Paris; APHP, University Hospitals Saint Louis Lariboisière, Inserm 942 MASCOT, Paris, France.
Pellicori P; Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Wellbeing, Glasgow, UK.
Sever P; International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, London, UK.
Staessen JA; Research Institute Alliance for the Promotion of Preventive Medicine, Mechelen, Belgium.; Biomedical Sciences Group, Faculty of Medicine, University of Leuven, Leuven, Belgium.
Thijs L; Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium.
Cleland JG; Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Wellbeing, Glasgow, UK.; National Heart and Lung Institute, Royal Brompton and Harefield Hospitals, Imperial College, University of Glasgow, London, UK.
Sattar N; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
Zannad F; Centre d'Investigations Cliniques Plurithématique 1433, Institut Lorrain du Cœur et des Vaisseaux Louis Mathieu, CHRU de Nancy, INSERM DCAC, F-CRIN INI-CRCT, Université de Lorraine, Nancy, France.
Girerd N; Centre d'Investigations Cliniques Plurithématique 1433, Institut Lorrain du Cœur et des Vaisseaux Louis Mathieu, CHRU de Nancy, INSERM DCAC, F-CRIN INI-CRCT, Université de Lorraine, Nancy, France.; Pokaż więcej
Źródło:: European journal of heart failure [Eur J Heart Fail] 2022 Jun; Vol. 24 (6), pp. 976-984. Date of Electronic Publication: 2022 Apr 18.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Diabetes Mellitus*
Heart Failure*/complications
Hypertension*/epidemiology
Myocardial Infarction*/complications
Biological Specimen Banks ; Humans ; Male ; Risk Factors ; United Kingdom/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Inflammation and remodeling pathways and risk of cardiovascular events in patients with ischemic heart failure and reduced ejection fraction.
Autorzy:: Girerd N; Université de Lorraine, Centre d'Investigation Clinique-Plurithématique Inserm CIC-P 1433, Inserm U1116, CHRU Nancy Brabois, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France.
Cleland J; Robertson Centre for Biostatistics and Clinical Trials, University of Glasgow, Glasgow, Scotland.
Anker SD; Department of Cardiology (CVK), and Berlin Institute of Health Center for Regenerative Therapies (BCRT), German Centre for Cardiovascular Research (DZHK) Partner Site Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany.
Byra W; Janssen Research and Development, Raritan, NJ, USA.
Lam CSP; National Heart Centre Singapore, Duke-National University of Singapore, Singapore, Singapore.
Lapolice D; Janssen Research and Development, Raritan, NJ, USA.
Mehra MR; Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
van Veldhuisen DJ; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Bresso E; Université de Lorraine, Centre d'Investigation Clinique-Plurithématique Inserm CIC-P 1433, Inserm U1116, CHRU Nancy Brabois, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France.
Lamiral Z; Université de Lorraine, Centre d'Investigation Clinique-Plurithématique Inserm CIC-P 1433, Inserm U1116, CHRU Nancy Brabois, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France.
Greenberg B; Cardiology Division, Department of Medicine, University of California, La Jolla, San Diego, USA.
Zannad F; Université de Lorraine, Centre d'Investigation Clinique-Plurithématique Inserm CIC-P 1433, Inserm U1116, CHRU Nancy Brabois, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France. f.zannad@chru-nancy.fr.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2022 May 20; Vol. 12 (1), pp. 8574. Date of Electronic Publication: 2022 May 20.
Typ publikacji:: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:: Atrial Remodeling*/physiology
Coronary Artery Disease*/complications
Coronary Artery Disease*/diagnosis
Heart Failure*/complications
Inflammation*/complications
Myocardial Infarction*/complications
Myocardial Infarction*/diagnosis
Stroke*/complications
Stroke*/diagnosis
Ventricular Dysfunction, Left*/complications
Biomarkers ; Case-Control Studies ; Death, Sudden, Cardiac ; Growth Differentiation Factor 15 ; Humans ; Natriuretic Peptide, Brain ; Peptide Fragments ; Proteomics ; Stroke Volume

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Antifibrotic effect of novel neutrophil gelatinase-associated lipocalin inhibitors in cardiac and renal disease models.
Autorzy:: Bonnard B; INSERM, UMRS 1138, Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, 15 rue de l'Ecole de Médecine, 75006, Paris, France.
Martínez-Martínez E; INSERM, UMRS 1138, Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, 15 rue de l'Ecole de Médecine, 75006, Paris, France.
Fernández-Celis A; Cardiovascular Translational Research, Navarrabiomed (Miguel Servet Foundation), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
Pieronne-Deperrois M; Inserm U1096, UFR Médecine-Pharmacie, Rouen, France.
Do QT; Greenpharma SAS, Orléans, France.
Ramos I; Innovative Technologies in Biological Systems SL (INNOPROT), Bizkaia, Spain.
Rossignol P; INSERM Centre d'Investigations Cliniques-Plurithématique 1433, UMR 1116, CHRU de Nancy, French-Clinical Research Infrastructure Network (F-CRIN) INI-CRCT, Université de Lorraine, Nancy, France.
Zannad F; INSERM Centre d'Investigations Cliniques-Plurithématique 1433, UMR 1116, CHRU de Nancy, French-Clinical Research Infrastructure Network (F-CRIN) INI-CRCT, Université de Lorraine, Nancy, France.
Mulder P; Inserm U1096, UFR Médecine-Pharmacie, Rouen, France.
Ouvrard-Pascaud A; Inserm U1096, UFR Médecine-Pharmacie, Rouen, France.
López-Andrés N; Cardiovascular Translational Research, Navarrabiomed (Miguel Servet Foundation), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.; INSERM Centre d'Investigations Cliniques-Plurithématique 1433, UMR 1116, CHRU de Nancy, French-Clinical Research Infrastructure Network (F-CRIN) INI-CRCT, Université de Lorraine, Nancy, France.
Jaisser F; INSERM, UMRS 1138, Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, 15 rue de l'Ecole de Médecine, 75006, Paris, France. .; INSERM Centre d'Investigations Cliniques-Plurithématique 1433, UMR 1116, CHRU de Nancy, French-Clinical Research Infrastructure Network (F-CRIN) INI-CRCT, Université de Lorraine, Nancy, France. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2021 Jan 28; Vol. 11 (1), pp. 2591. Date of Electronic Publication: 2021 Jan 28.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Lipocalin-2/*antagonists & inhibitors
Lipocalin-2/*metabolism
Myocardial Infarction/*drug therapy
Myocardial Infarction/*metabolism
Renal Insufficiency, Chronic/*drug therapy
Renal Insufficiency, Chronic/*metabolism
Animals ; Disease Models, Animal ; Drug Discovery ; Drug Evaluation, Preclinical ; Male ; Mice

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Acute myocardial infarction and acute heart failure in the Middle East and North Africa: Study design and pilot phase study results from the PEACE MENA registry.
Autorzy:: Alhabib KF; Department of Cardiac Sciences, King Fahad Cardiac Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Gamra H; Research Laboratory LR 12SP16, Fattouma Bourguiba University Hospital, University of Monastir, Monastir, Tunisia.
Almahmeed W; Heart and Vascular Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirate.
Hammoudeh A; Cardiology Department, Istishari Hospital, Amman, Jordan.
Benkheddah S; Cardiology Department, Mustapha Hospital, University Benyoucef Benkhedda, Alger Ctre, Algeria.
Al Jarallah M; Sabah Al-Ahmad Cardia Center, Kuwait City, Kuwait.
Al-Motarreb A; Faculty of Medicine, Sana'a University, Sana'a, Yemen.
Alquraishi M; Ibn-Albitar Hospital for Cardiac Surgery, Baghdad, Iraq.
Sobhy M; International Cardiac Center (ICC), Alexandria, Egypt.
Yousif MG; Sudan Heart Centre, Khartoum, Sudan.
Alkindi F; Heart Hospital, Hamad Medical Corporation, Doha, Qatar.
Fellat N; IBN SINA University Hospital, Rabat, Morocco.
Amin MI; Sh. Mohammad Bin Khalifa Cardiac Centre, Awali, Bahrain.
Ali M; Saudi Heart Association, Riyadh, Saudi Arabia.
Al Saleh A; Department of Cardiac Sciences, King Fahad Cardiac Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Ullah A; Department of Cardiac Sciences, King Fahad Cardiac Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Zannad F; Centre d'Investigation Clinique Inserm, Institut Lorrain du Coeur et des Vaisseaux, Université de Lorraine, CHU, Nancy, France.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2020 Jul 22; Vol. 15 (7), pp. e0236292. Date of Electronic Publication: 2020 Jul 22 (Print Publication: 2020).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Heart Failure/*epidemiology
Myocardial Infarction/*epidemiology
Registries/*statistics & numerical data
Africa, Northern/epidemiology ; Aged ; Female ; Hospital Mortality ; Humans ; Male ; Middle Aged ; Middle East/epidemiology ; Pilot Projects ; Prevalence ; Proof of Concept Study ; Prospective Studies ; Research Design ; Risk Assessment ; Risk Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Eplerenone prevents an increase in serum carboxy-terminal propeptide of procollagen type I after myocardial infarction complicated by left ventricular dysfunction and/or heart failure.
Autorzy:: Stienen S; Université de Lorraine, INSERM, Centre d'Investigations Cliniques Plurithématique 1433, INSERM U1116, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France.
Ferreira JP; Université de Lorraine, INSERM, Centre d'Investigations Cliniques Plurithématique 1433, INSERM U1116, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France.
Pitt B; Department of Medicine, University of Michigan School of Medicine, Ann Arbor, Michigan, USA.
Cleland JG; Robertson Centre for Biostatistics and Clinical Trials, University of Glasgow and National Heart & Lung Institute, London, UK.
Pellicori P; Robertson Centre for Biostatistics and Clinical Trials, University of Glasgow and National Heart & Lung Institute, London, UK.
Girerd N; Université de Lorraine, INSERM, Centre d'Investigations Cliniques Plurithématique 1433, INSERM U1116, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France.
Rossignol P; Université de Lorraine, INSERM, Centre d'Investigations Cliniques Plurithématique 1433, INSERM U1116, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France.
Zannad F; Université de Lorraine, INSERM, Centre d'Investigations Cliniques Plurithématique 1433, INSERM U1116, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France.; Pokaż więcej
Źródło:: European journal of heart failure [Eur J Heart Fail] 2020 May; Vol. 22 (5), pp. 901-903. Date of Electronic Publication: 2020 Apr 03.
Typ publikacji:: Letter; Research Support, Non-U.S. Gov't
MeSH Terms:: Heart Failure*/drug therapy
Myocardial Infarction*/complications
Myocardial Infarction*/drug therapy
Ventricular Dysfunction, Left*/diagnosis
Collagen Type I ; Eplerenone ; Humans ; Mineralocorticoid Receptor Antagonists/therapeutic use ; Peptide Fragments ; Procollagen ; Spironolactone

Raport

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Predictors of sudden cardiac death in high-risk patients following a myocardial infarction.
Autorzy:: Docherty KF; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Ferreira JP; Université de Lorraine INSERM, Centre, d'Investigations Cliniques Plurithématique 1433, INSERM U1116, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France.; Department of Physiology and Cardiothoracic Surgery, Cardiovascular Research and Development Unit, Faculty of Medicine, University of Porto, Porto, Portugal.
Sharma A; Division of Cardiology, McGill University Health Centre, Montreal, Canada.
Girerd N; Université de Lorraine INSERM, Centre, d'Investigations Cliniques Plurithématique 1433, INSERM U1116, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France.
Gregson J; Department of Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK.
Duarte K; Université de Lorraine INSERM, Centre, d'Investigations Cliniques Plurithématique 1433, INSERM U1116, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France.
Petrie MC; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Jhund PS; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Dickstein K; Department of Cardiology, University of Bergan, Stavanger University Hospital, Stavanger, Norway.
Pfeffer MA; Division of Cardiovascular Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
Pitt B; Department of Medicine, University of Michigan School of Medicine, Ann Arbor, MI, USA.
Rossignol P; Université de Lorraine INSERM, Centre, d'Investigations Cliniques Plurithématique 1433, INSERM U1116, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France.
Zannad F; Université de Lorraine INSERM, Centre, d'Investigations Cliniques Plurithématique 1433, INSERM U1116, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France.
McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.; Pokaż więcej
Źródło:: European journal of heart failure [Eur J Heart Fail] 2020 May; Vol. 22 (5), pp. 848-855. Date of Electronic Publication: 2020 Jan 16.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Heart Failure*/complications
Heart Failure*/epidemiology
Myocardial Infarction*/complications
Myocardial Infarction*/epidemiology
Aged ; Death, Sudden, Cardiac/epidemiology ; Death, Sudden, Cardiac/etiology ; Death, Sudden, Cardiac/prevention & control ; Humans ; Risk Factors ; Stroke Volume ; Ventricular Dysfunction, Left/epidemiology ; Ventricular Function, Left

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Association of diabetes and kidney function according to age and systolic function with the incidence of sudden cardiac death and non-sudden cardiac death in myocardial infarction survivors with heart failure.
Autorzy:: Coiro S; Division of Cardiology, University of Perugia, Ospedale S. Maria della Misericordia, Perugia, Italy.; INSERM, Centred'Investigation Clinique -1433 and Unité 1116, Nancy, France.; CHU Nancy, Institut Lorraindu Cœur et des Vaisseaux, Vandoeuvre lès, Nancy, France.; Université de Lorraine, Nancy, France.; F-CRIN INI-CRCT (Cardiovascular and RenalClinical Trialists) Network, Nancy, France.
Girerd N; INSERM, Centred'Investigation Clinique -1433 and Unité 1116, Nancy, France.; CHU Nancy, Institut Lorraindu Cœur et des Vaisseaux, Vandoeuvre lès, Nancy, France.; Université de Lorraine, Nancy, France.; F-CRIN INI-CRCT (Cardiovascular and RenalClinical Trialists) Network, Nancy, France.
Sharma A; Duke Clinical Research Institute, Duke University, Durham, NC, USA.; University of Alberta, Edmonton, Alberta, Canada.; Stanford University, Palo Alto, CA, USA.
Rossignol P; INSERM, Centred'Investigation Clinique -1433 and Unité 1116, Nancy, France.; CHU Nancy, Institut Lorraindu Cœur et des Vaisseaux, Vandoeuvre lès, Nancy, France.; Université de Lorraine, Nancy, France.; F-CRIN INI-CRCT (Cardiovascular and RenalClinical Trialists) Network, Nancy, France.
Tritto I; Division of Cardiology, University of Perugia, Ospedale S. Maria della Misericordia, Perugia, Italy.
Pitt B; University of Michigan, Ann Arbor, MI, USA.
Pfeffer MA; Division of Cardiology, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Ambrosio G; Division of Cardiology, University of Perugia, Ospedale S. Maria della Misericordia, Perugia, Italy.
Dickstein K; Division of Cardiology, Stavanger University Hospital, Stavanger, Norway.; Institute of Internal Medicine, University of Bergen, Bergen, Norway.
Moss A; Heart Research Follow-up Program, University of Rochester Medical Center, Rochester, NY, USA.
Zannad F; INSERM, Centred'Investigation Clinique -1433 and Unité 1116, Nancy, France.; CHU Nancy, Institut Lorraindu Cœur et des Vaisseaux, Vandoeuvre lès, Nancy, France.; Université de Lorraine, Nancy, France.; F-CRIN INI-CRCT (Cardiovascular and RenalClinical Trialists) Network, Nancy, France.; Pokaż więcej
Źródło:: European journal of heart failure [Eur J Heart Fail] 2019 Oct; Vol. 21 (10), pp. 1248-1258. Date of Electronic Publication: 2019 Sep 02.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Death, Sudden, Cardiac/*epidemiology
Diabetes Complications/*mortality
Heart Failure/*mortality
Myocardial Infarction/*complications
Adult ; Age Factors ; Aged ; Female ; Humans ; Incidence ; Kidney Function Tests ; Male ; Middle Aged ; Risk Assessment ; Risk Factors ; Survivors ; Systole

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Association between mean systolic and diastolic blood pressure throughout the follow-up and cardiovascular events in acute myocardial infarction patients with systolic dysfunction and/or heart failure: an analysis from the High-Risk Myocardial Infarction Database Initiative.
Autorzy:: Ferreira JP; INSERM, Centre, d'Investigations Cliniques Plurithématique 1433, INSERM U1116, Université de Lorraine, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France.; Department of Physiology and Cardiothoracic Surgery, Cardiovascular Research and Development Unit, Faculty of Medicine, University of Porto, Porto, Portugal.
Duarte K; Université de Lorraine, Institut Elie Cartan de Lorraine, UMR 7502, Vandoeuvre-lès-Nancy, France.; CNRS, Institut Elie Cartan de Lorraine, UMR 7502, Vandoeuvre-lès-Nancy, France.; Team BIGS, INRIA, Villers-lès-Nancy, France.
Pfeffer MA; Division of Cardiovascular Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, UK.
Pitt B; Department of Medicine, University of Michigan School of Medicine, Ann Arbor, MI, USA.
Dickstein K; Department of Cardiology, University of Bergan, Stavanger University Hospital, Stavanger, Norway.
Zannad F; INSERM, Centre, d'Investigations Cliniques Plurithématique 1433, INSERM U1116, Université de Lorraine, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France.
Rossignol P; INSERM, Centre, d'Investigations Cliniques Plurithématique 1433, INSERM U1116, Université de Lorraine, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France.; Pokaż więcej
Corporate Authors:: High-Risk Myocardial Infarction Database Initiative
Źródło:: European journal of heart failure [Eur J Heart Fail] 2018 Feb; Vol. 20 (2), pp. 323-331. Date of Electronic Publication: 2018 Jan 04.
Typ publikacji:: Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:: Registries*
Blood Pressure/*physiology
Heart Failure, Diastolic/*physiopathology
Heart Failure, Systolic/*physiopathology
Myocardial Infarction/*complications
Aged ; Cause of Death/trends ; Diastole ; Europe/epidemiology ; Female ; Follow-Up Studies ; Heart Failure, Diastolic/complications ; Heart Failure, Diastolic/mortality ; Heart Failure, Systolic/complications ; Heart Failure, Systolic/mortality ; Hospitalization/trends ; Humans ; Male ; Middle Aged ; Myocardial Infarction/mortality ; Myocardial Infarction/physiopathology ; Prognosis ; Retrospective Studies ; Risk Factors ; Survival Rate/trends ; Systole ; United States/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: A history of diabetes predicts outcomes following myocardial infarction: an analysis of the 28 771 patients in the High-Risk MI Database.
Autorzy:: Tajik AA; Stavanger University Hospital, Stavanger, Norway.
Dobre D; Nancy University Hospital, Nancy, France.; Psychotherapeutic Centre, Nancy, France.
Aguilar D; Baylor College of Medicine, Houston, TX, 77030, USA.
Kjekshus J; University of Oslo, Oslo, Norway.
Zannad F; Nancy University Hospital, Nancy, France.
Dickstein K; University of Bergen, Stavanger University Hospital, Stavanger, Norway.; Pokaż więcej
Corporate Authors:: High-Risk MI Database Scientific Committee
Źródło:: European journal of heart failure [Eur J Heart Fail] 2017 May; Vol. 19 (5), pp. 635-642.
Typ publikacji:: Journal Article; Multicenter Study
MeSH Terms:: Diabetes Mellitus, Type 1/*complications
Diabetes Mellitus, Type 2/*complications
Myocardial Infarction/*complications
Risk Assessment/*statistics & numerical data
Ventricular Dysfunction, Left/*etiology
Ventricular Function, Left/*physiology
Aged ; Cause of Death/trends ; Diabetes Mellitus, Type 1/mortality ; Diabetes Mellitus, Type 2/mortality ; Female ; Global Health ; Humans ; Male ; Myocardial Infarction/mortality ; Myocardial Infarction/physiopathology ; Randomized Controlled Trials as Topic ; Risk Factors ; Ventricular Dysfunction, Left/mortality ; Ventricular Dysfunction, Left/physiopathology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myocardial Infarction Database Initiative.
Autorzy:: Coiro S; INSERM, Centre d'Investigations Cliniques 9501, Université de Lorraine, CHU de Nancy, Institut Lorrain du Cœur et des Vaisseaux, Nancy, France.; INI-CRCT (Cardiovascular and Renal Clinical Trialists) F-CRIN network, Nancy, France.; Division of Cardiology, University of Perugia, Ospedale S. Maria della Misericordia, Perugia, Italy.
Girerd N; INSERM, Centre d'Investigations Cliniques 9501, Université de Lorraine, CHU de Nancy, Institut Lorrain du Cœur et des Vaisseaux, Nancy, France.; INI-CRCT (Cardiovascular and Renal Clinical Trialists) F-CRIN network, Nancy, France.
Rossignol P; INSERM, Centre d'Investigations Cliniques 9501, Université de Lorraine, CHU de Nancy, Institut Lorrain du Cœur et des Vaisseaux, Nancy, France.; INI-CRCT (Cardiovascular and Renal Clinical Trialists) F-CRIN network, Nancy, France.
Ferreira JP; INSERM, Centre d'Investigations Cliniques 9501, Université de Lorraine, CHU de Nancy, Institut Lorrain du Cœur et des Vaisseaux, Nancy, France.; INI-CRCT (Cardiovascular and Renal Clinical Trialists) F-CRIN network, Nancy, France.; Department of Physiology and Cardiothoracic Surgery, Cardiovascular Research and Development Unit, Faculty of Medicine, University of Porto, Porto, Portugal.
Maggioni A; ANMCO Research Centre, Firenze, Italy.
Pitt B; Cardiology Division, University of Michigan School of Medicine, Ann Arbor, MI, USA.
Tritto I; Division of Cardiology, University of Perugia, Ospedale S. Maria della Misericordia, Perugia, Italy.
Ambrosio G; Division of Cardiology, University of Perugia, Ospedale S. Maria della Misericordia, Perugia, Italy.
Dickstein K; University of Bergen, Stavanger University Hospital, Stavanger, Norway.
Zannad F; INSERM, Centre d'Investigations Cliniques 9501, Université de Lorraine, CHU de Nancy, Institut Lorrain du Cœur et des Vaisseaux, Nancy, France.; INI-CRCT (Cardiovascular and Renal Clinical Trialists) F-CRIN network, Nancy, France.; Pokaż więcej
Źródło:: European journal of heart failure [Eur J Heart Fail] 2017 Feb; Vol. 19 (2), pp. 271-279. Date of Electronic Publication: 2016 Oct 24.
Typ publikacji:: Journal Article
MeSH Terms:: Mortality*
Adrenergic beta-Antagonists/*therapeutic use
Heart Failure/*drug therapy
Myocardial Infarction/*drug therapy
Pulmonary Disease, Chronic Obstructive/*complications
Ventricular Dysfunction, Left/*drug therapy
Aged ; Cardiovascular Diseases/mortality ; Cause of Death ; Cohort Studies ; Databases, Factual ; Female ; Heart Failure/complications ; Humans ; Male ; Middle Aged ; Myocardial Infarction/complications ; Prognosis ; Propensity Score ; Proportional Hazards Models ; Protective Factors ; Ventricular Dysfunction, Left/complications

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Prediction of Left Ventricular Remodeling after a Myocardial Infarction: Role of Myocardial Deformation: A Systematic Review and Meta-Analysis.
Autorzy:: Huttin O; Centre Hospitalier Universitaire de Nancy, Service de Cardiologie, Institut Lorrain du Cœur et des Vaisseaux, Nancy, France.; Centre d'Investigations Cliniques- Plurithématique 14-33, and Institut national de la santé et de la recherche médicale U1116, Nancy, France.; Centre Hospitalier Universitaire, Pôle de Cardiologie, Institut Lorrain du Cœur et des Vaisseaux, Vandoeuvre lès Nancy, Nancy, France.
Coiro S; Centre d'Investigations Cliniques- Plurithématique 14-33, and Institut national de la santé et de la recherche médicale U1116, Nancy, France.
Selton-Suty C; Centre Hospitalier Universitaire de Nancy, Service de Cardiologie, Institut Lorrain du Cœur et des Vaisseaux, Nancy, France.; Centre Hospitalier Universitaire, Pôle de Cardiologie, Institut Lorrain du Cœur et des Vaisseaux, Vandoeuvre lès Nancy, Nancy, France.
Juillière Y; Centre Hospitalier Universitaire de Nancy, Service de Cardiologie, Institut Lorrain du Cœur et des Vaisseaux, Nancy, France.; Centre Hospitalier Universitaire, Pôle de Cardiologie, Institut Lorrain du Cœur et des Vaisseaux, Vandoeuvre lès Nancy, Nancy, France.; Université de Lorraine, Nancy, France.
Donal E; Département de Cardiologie & CIC-IT U 804, Centre, Hospitalier Universitaire de Rennes, LTSI, Université Rennes 1, INSERM 1099, Rennes, France.
Magne J; Centre Hospitalier Universitaire Limoges, Hôpital Dupuytren, Department of Cardiology, Limoges, France.
Sadoul N; Centre Hospitalier Universitaire de Nancy, Service de Cardiologie, Institut Lorrain du Cœur et des Vaisseaux, Nancy, France.; Centre Hospitalier Universitaire, Pôle de Cardiologie, Institut Lorrain du Cœur et des Vaisseaux, Vandoeuvre lès Nancy, Nancy, France.; Université de Lorraine, Nancy, France.
Zannad F; Centre Hospitalier Universitaire de Nancy, Service de Cardiologie, Institut Lorrain du Cœur et des Vaisseaux, Nancy, France.; Centre d'Investigations Cliniques- Plurithématique 14-33, and Institut national de la santé et de la recherche médicale U1116, Nancy, France.; Université de Lorraine, Nancy, France.
Rossignol P; Centre d'Investigations Cliniques- Plurithématique 14-33, and Institut national de la santé et de la recherche médicale U1116, Nancy, France.; Université de Lorraine, Nancy, France.; Investigation Network Initiative Cardiovascular and Renal Clinical Trialists, Nancy, France.
Girerd N; Centre d'Investigations Cliniques- Plurithématique 14-33, and Institut national de la santé et de la recherche médicale U1116, Nancy, France.; Université de Lorraine, Nancy, France.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2016 Dec 30; Vol. 11 (12), pp. e0168349. Date of Electronic Publication: 2016 Dec 30 (Print Publication: 2016).
Typ publikacji:: Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:: Heart Ventricles/*physiopathology
Myocardial Infarction/*physiopathology
Myocardium/*pathology
Ventricular Function, Left/*physiology
Ventricular Remodeling/*physiology
Echocardiography/methods ; Humans ; Prospective Studies

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Renal function estimation and Cockroft-Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: The Heart 'OMics' in AGEing (HOMAGE) and the high-risk myocardial infarction database initiatives.
Autorzy:: Ferreira JP; INSERM, Centre d'Investigations Cliniques Plurithématique 1433, INSERM U1116, Université de Lorraine, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France.
Girerd N; INSERM, Centre d'Investigations Cliniques Plurithématique 1433, INSERM U1116, Université de Lorraine, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France.
Pellicori P; Academic Cardiology Unit, University of Hull, Castle Hill Hospital, Kingston upon Hull, UK.
Duarte K; Université de Lorraine, Institut Elie Cartan de Lorraine, UMR 7502,, Vandoeuvre-lès-Nancy, F-54506, France.; CNRS, Institut Elie Cartan de Lorraine, UMR 7502,, Vandoeuvre-lès-Nancy, F-54506, France.; Team BIGS, INRIA, Villers-lès-Nancy, F-54600, France.
Girerd S; INSERM, Centre d'Investigations Cliniques Plurithématique 1433, INSERM U1116, Université de Lorraine, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France.
Pfeffer MA; Division of Cardiovascular Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts, 02115, USA.
McMurray JJ; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, UK.
Pitt B; Department of Medicine, University of Michigan School of Medicine, Ann Arbor, MA, USA.; ASH Comprehensive Hypertension Center, Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, The University of Chicago, Chicago, IL, USA.
Dickstein K; Department of Cardiology, University of Bergan, Stavanger University Hospital, Stavanger, Norway.
Jacobs L; Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.
Staessen JA; Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.
Butler J; Cardiology Division, Stony Brook University, Stony Brook, NY, USA.
Latini R; Laboratory of Cardiovascular Clinical Pharmacology, IRCCS - Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy.
Masson S; Laboratory of Cardiovascular Clinical Pharmacology, IRCCS - Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy.
Mebazaa A; Hôpital Lariboisière, Université Paris Diderot, Inserm 942, Paris, France.
Rocca HP; Cardiovascular Research Institute Maastricht, Maastricht University Medical Centre, Maastricht, The Netherlands Department of Cardiology, Maastricht University Medical Centre, Maastricht, The Netherlands.
Delles C; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, UK.
Heymans S; Department of Cardiology, Maastricht University Medical Center, Postbox 5800, 6202, AZ, Maastricht, The Netherlands.
Sattar N; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland, UK.
Jukema JW; Department of Cardiology and Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands.; Interuniversity Cardiology Institute of the Netherlands, Utrecht, The Netherlands.
Cleland JG; National Heart and Lung Institute, Imperial College London (Royal Brompton and Harefield Hospitals) Department of Cardiology, Castle Hill Hospital, University of Hull, Hull, UK.
Zannad F; INSERM, Centre d'Investigations Cliniques Plurithématique 1433, INSERM U1116, Université de Lorraine, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France.
Rossignol P; INSERM, Centre d'Investigations Cliniques Plurithématique 1433, INSERM U1116, Université de Lorraine, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France. .; Centre d'Investigations Cliniques-INSERM CHU de Nancy, Institut Lorrain du Cœur et des Vaisseaux Louis Mathieu, 4 Rue du Morvan, 54500, Vandoeuvre lès Nancy, France. .; Pokaż więcej
Corporate Authors:: Heart ‘OMics’ in AGEing (HOMAGE) initiative and the High-Risk Myocardial Infarction database initiative
Źródło:: BMC medicine [BMC Med] 2016 Nov 10; Vol. 14 (1), pp. 181. Date of Electronic Publication: 2016 Nov 10.
Typ publikacji:: Journal Article; Randomized Controlled Trial
MeSH Terms:: Population Surveillance*/methods
Aging/*physiology
Heart Failure/*mortality
Kidney/*physiology
Myocardial Infarction/*mortality
Renal Insufficiency, Chronic/*mortality
Adult ; Aged ; Aged, 80 and over ; Cardiovascular Diseases/diagnosis ; Cardiovascular Diseases/mortality ; Cardiovascular Diseases/physiopathology ; Cohort Studies ; Databases, Factual/trends ; Female ; Glomerular Filtration Rate/physiology ; Heart Failure/diagnosis ; Heart Failure/physiopathology ; Humans ; Male ; Middle Aged ; Myocardial Infarction/diagnosis ; Myocardial Infarction/physiopathology ; Predictive Value of Tests ; Renal Insufficiency, Chronic/diagnosis ; Renal Insufficiency, Chronic/physiopathology ; Risk Factors

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High-Risk Myocardial Infarction Database Initiative.
Autorzy:: von Lueder TG; Department of Cardiology B, Division of Medicine, Oslo University Hospital Ullevål, University of Oslo, Norway.; Center for Heart Failure Research, University of Oslo, Norway.
Girerd N; INSERM, Centre d'Investigations Cliniques-1433, and INSERM U1116, Nancy, France.; CHU Nancy, Institut Lorrain du Cœur et des Vaisseaux, Vandoeuvre lès Nancy, France.; Université de Lorraine, Nancy, France.; F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists) Network, Nancy, France.
Atar D; Department of Cardiology B, Division of Medicine, Oslo University Hospital Ullevål, University of Oslo, Norway.; Center for Heart Failure Research, University of Oslo, Norway.
Agewall S; Department of Cardiology B, Division of Medicine, Oslo University Hospital Ullevål, University of Oslo, Norway.; Center for Heart Failure Research, University of Oslo, Norway.
Lamiral Z; INSERM, Centre d'Investigations Cliniques-1433, and INSERM U1116, Nancy, France.; CHU Nancy, Institut Lorrain du Cœur et des Vaisseaux, Vandoeuvre lès Nancy, France.; Université de Lorraine, Nancy, France.; F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists) Network, Nancy, France.
Kanbay M; Department of Medicine, Division of Nephrology, Koc University School of Medicine, Istanbul, Turkey.
Pitt B; University of Michigan School of Medicine, Ann Arbor, MI, USA.
Dickstein K; Division of Cardiology, University of Bergen, Stavanger University Hospital, Stavanger, Norway.
Zannad F; INSERM, Centre d'Investigations Cliniques-1433, and INSERM U1116, Nancy, France.; CHU Nancy, Institut Lorrain du Cœur et des Vaisseaux, Vandoeuvre lès Nancy, France.; Université de Lorraine, Nancy, France.; F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists) Network, Nancy, France.
Rossignol P; INSERM, Centre d'Investigations Cliniques-1433, and INSERM U1116, Nancy, France.; CHU Nancy, Institut Lorrain du Cœur et des Vaisseaux, Vandoeuvre lès Nancy, France.; Université de Lorraine, Nancy, France.; F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists) Network, Nancy, France.; Pokaż więcej
Corporate Authors:: High-Risk Myocardial Infarction Database Initiative Investigators
Źródło:: European journal of heart failure [Eur J Heart Fail] 2015 Nov; Vol. 17 (11), pp. 1144-51. Date of Electronic Publication: 2015 Oct 01.
Typ publikacji:: Journal Article; Randomized Controlled Trial
MeSH Terms:: Heart Failure*/blood
Heart Failure*/diagnosis
Heart Failure*/etiology
Heart Failure*/physiopathology
Myocardial Infarction*/complications
Myocardial Infarction*/mortality
Ventricular Dysfunction, Left*/blood
Ventricular Dysfunction, Left*/diagnosis
Ventricular Dysfunction, Left*/etiology
Ventricular Dysfunction, Left*/physiopathology
Uric Acid/*blood
Aged ; Biomarkers/blood ; Female ; Hospitalization/statistics & numerical data ; Humans ; Male ; Middle Aged ; Predictive Value of Tests ; Prognosis ; Proportional Hazards Models ; Risk Factors ; Statistics as Topic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Rationale and design of a randomized, double-blind, event-driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an exacerbation of heart failure: the COMMANDER HF trial.
Autorzy:: Zannad F; Inserm Centre d'Investigation Clinique CIC 1433, UMR 1116, CHU de Nancy, Institut Lorrain du Coeur et des Vaisseaux, Université de Lorraine, Nancy, France.
Greenberg B; Department of Medicine, Cardiology Division, University of California, San Diego, La Jolla, CA, USA.
Cleland JG; National Heart and Lung Institute, Royal Brompton and Harefield Hospitals, Imperial College, London, England.
Gheorghiade M; Center for Cardiovascular Innovation, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
van Veldhuisen DJ; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Mehra MR; Brigham and Women's Hospital Heart and Vascular Center, and Harvard Medical School, Boston, MA, USA.
Anker SD; Division of Innovative Clinical Trials, Department of Cardiology, University Medical Centre Göttingen (UMG), Göttingen, Germany.
Byra WM; Janssen Research & Development, LLC, 920 US 202, Raritan, NJ, USA.
Fu M; Janssen Research & Development, LLC, 920 US 202, Raritan, NJ, USA.
Mills RM; Janssen Research & Development, LLC, 920 US 202, Raritan, NJ, USA.; Pokaż więcej
Źródło:: European journal of heart failure [Eur J Heart Fail] 2015 Jul; Vol. 17 (7), pp. 735-42. Date of Electronic Publication: 2015 Apr 27.
Typ publikacji:: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:: Research Design*
Coronary Artery Disease/*drug therapy
Factor Xa Inhibitors/*therapeutic use
Heart Failure/*drug therapy
Myocardial Infarction/*prevention & control
Rivaroxaban/*therapeutic use
Stroke/*prevention & control
Administration, Oral ; Coronary Artery Disease/mortality ; Double-Blind Method ; Heart Failure/mortality ; Humans ; Prospective Studies ; Risk Factors ; Survival Rate